Fizimed
Connected medical devices for at-home pelvic floor rehabilitation.
- B2C
- manufacturing
- selling own inventory
- health
- wellness beauty
- health platform
- medical devices
- mobile app
- hardware
- deep tech
- dt and ls
- horizon europe
- sustainable development goals
- woman founder
- radar de l'innovation
- eit ecosystem
- observatoire deeptech
- digital care
- eit health
- biotech, medtech and e-health
- direct-to-consumer
- eit supernovas
- vivatech2019
- femtech
- remote health monitoring
- remote monitoring
- sextech
- patient engagement
- investor network (eit health)
- women's health
- bridgehead europe (eit health)
- investor network 2018 (eit health)
- bridgehead europe 2019 (eit health)
- pelvic health
- bridgehead global 2020 (eit health)
- bridgehead global (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €4.0m | Early VC | |
| Total Funding | 000k | ||
Related Content
Fizimed is a French femtech company founded in 2017 by Emeline Hahn, Julien Guay, Allan Mabilais, and Paul Grandemange, specializing in connected medical devices for women's health. The founders initially planned to develop a connected prosthetic knee for athletes but pivoted after discovering a significant unmet need for at-home pelvic floor rehabilitation. CEO Emeline Hahn, a research engineer with a background in microbiology, analytical chemistry, and pharmaceutical management, chose to base the company in Strasbourg to leverage the region's strong health and innovation ecosystem.
The company's flagship product is the Emy Kegel trainer, a patented, FDA-registered medical device designed to help women strengthen their pelvic floor muscles to address issues like urinary incontinence, aid in postpartum recovery, and improve intimate well-being. The Emy trainer uses biofeedback technology, with sensors that measure pelvic muscle contractions in real-time. These contractions control games within a connected mobile application, creating a personalized and engaging training program based on medical protocols. Fizimed also produces the Emy Pump, a hands-free breast pump.
Fizimed operates in the femtech and health tech markets, selling its products directly to consumers and through partnerships. The company has gained traction in Europe, with its pelvic floor trainer being covered by health insurance in Germany. In March 2025, Fizimed raised €4 million in a Series A funding round led by Bpifrance, with support from UNIQA and UI Investissement, to accelerate its international expansion, particularly into the United States and German-speaking countries. The company emphasizes high-quality, eco-conscious manufacturing, primarily using materials sourced from France.
Keywords: femtech, medical device, women's health, pelvic floor trainer, Kegel trainer, biofeedback, urinary incontinence, postpartum recovery, Emy trainer, health tech, connected health, mHealth, eHealth, rehabilitation device, bladder control, at-home healthcare, medical innovation, digital health, Strasbourg, Emeline Hahn